457 related articles for article (PubMed ID: 16442037)
1. Comparative evaluation of the safety and efficacy of botulinum toxin type A and topical creams for treating moderate-to-severe glabellar rhytids.
Beer KR
Dermatol Surg; 2006 Feb; 32(2):184-97. PubMed ID: 16442037
[TBL] [Abstract][Full Text] [Related]
2. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids.
Carruthers A; Carruthers J
Dermatol Surg; 2005 Oct; 31(10):1297-303. PubMed ID: 16188182
[TBL] [Abstract][Full Text] [Related]
3. Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial.
Dubina M; Tung R; Bolotin D; Mahoney AM; Tayebi B; Sato M; Mulinari-Brenner F; Jones T; West DP; Poon E; Nodzenski M; Alam M
J Cosmet Dermatol; 2013 Dec; 12(4):261-6. PubMed ID: 24305424
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines.
Carruthers JD; Lowe NJ; Menter MA; Gibson J; Eadie N;
Plast Reconstr Surg; 2003 Sep; 112(4):1089-98. PubMed ID: 12973229
[TBL] [Abstract][Full Text] [Related]
5. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females.
Carruthers A; Carruthers J; Said S
Dermatol Surg; 2005 Apr; 31(4):414-22; discussion 422. PubMed ID: 15871316
[TBL] [Abstract][Full Text] [Related]
6. A prospective, double-blind, randomized, parallel- group, dose-ranging study of botulinum toxin type a in female subjects with horizontal forehead rhytides.
Carruthers A; Carruthers J; Cohen J
Dermatol Surg; 2003 May; 29(5):461-7. PubMed ID: 12752512
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines.
Kim JE; Song EJ; Choi GS; Lew BL; Sim WY; Kang H
Plast Reconstr Surg; 2015 Mar; 135(3):732-741. PubMed ID: 25719692
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.
Wu Y; Fang F; Lai W; Li C; Li L; Liu Q; Lu J; Pang X; Sun J; Shi X; Picaut P; Prygova I; Andriopoulos B; Sun Q
Aesthetic Plast Surg; 2023 Feb; 47(1):351-364. PubMed ID: 36536093
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin A (Botox Cosmetic): a review of its use in the treatment of glabellar frown lines.
Frampton JE; Easthope SE
Am J Clin Dermatol; 2003; 4(10):709-25. PubMed ID: 14507232
[TBL] [Abstract][Full Text] [Related]
10. Botox and collagen for glabellar furrows: advantages of combination therapy.
Patel MP; Talmor M; Nolan WB
Ann Plast Surg; 2004 May; 52(5):442-7; discussion 447. PubMed ID: 15096921
[TBL] [Abstract][Full Text] [Related]
11. A four-month randomized, double-blind evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types V and VI.
Grimes PE; Shabazz D
Dermatol Surg; 2009 Mar; 35(3):429-35; discussion 435-6. PubMed ID: 19250310
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.
Carruthers JA; Lowe NJ; Menter MA; Gibson J; Nordquist M; Mordaunt J; Walker P; Eadie N;
J Am Acad Dermatol; 2002 Jun; 46(6):840-9. PubMed ID: 12063480
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
[TBL] [Abstract][Full Text] [Related]
14. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety.
Brandt F; Swanson N; Baumann L; Huber B
Dermatol Surg; 2009 Dec; 35(12):1893-901. PubMed ID: 19549186
[TBL] [Abstract][Full Text] [Related]
15. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
Beer KR; Julius H; Dunn M; Wilson F
J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
[TBL] [Abstract][Full Text] [Related]
16. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?
Carruthers A; Carruthers J; Cohen J
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S97-104. PubMed ID: 17241422
[TBL] [Abstract][Full Text] [Related]
17. Comparative trial of a novel botulinum neurotoxin type A versus onabotulinumtoxinA in the treatment of glabellar lines: a multicenter, randomized, double-blind, active-controlled study.
Won CH; Kim HK; Kim BJ; Kang H; Hong JP; Lee SY; Kim CS
Int J Dermatol; 2015 Feb; 54(2):227-34. PubMed ID: 25311357
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids.
Hui JI; Lee WW
Ophthalmic Plast Reconstr Surg; 2007; 23(6):433-8. PubMed ID: 18030112
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study.
Fagien S; Cox SE; Finn JC; Werschler WP; Kowalski JW
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S2-9. PubMed ID: 17241410
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians.
Choi SY; Koh YG; Lee YW; Son HS; Yoon YN; Kim G; Won C; Cho H; Son JS; Kim EK; Kim BJ
J Dermatolog Treat; 2024 Dec; 35(1):2359511. PubMed ID: 38880494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]